Omada Health OMDA

Omada Health reports strong Q3 2026 results

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Revenue of $91 million, up 34% year over year
  2. Total members reached 1.1 million, up 36% year over year
  3. Adjusted EBITDA of $12 million, up from $2 million in Q3 2025
  4. Raises full year 2026 revenue guidance to $344 million to $346 million

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get an email when Omada Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

The reading, claim by claim

  1. The filing includes a press release with financial highlights and operational data.
  2. The press release is incorporated by reference into the Form 8-K.
  3. Gross margin for the quarter was 76%, compared to 66% in the third quarter of 2025.
  4. Net income was $7 million, versus a net loss of $3 million in the third quarter of 2025.
  5. Omada Health reported 1.1 million total members as of September 30, 2026, a 36% increase from the same period in 2025.
  6. Average member tenure grew 10% year over year to approximately 2 years and 4 months.
  7. The company raised its full-year 2026 revenue outlook to $344 million to $346 million, up from $334 million to $340 million.
  8. The press release includes a forward-looking financial outlook for 2026, but the company did not provide a GAAP net income outlook due to complexity in reconciling Adjusted EBITDA.
  9. A conference call was held on November 5, 2026, to discuss the results.

9 of 9 claims matched the filing text.

For perspective, checked against its own source

From the 10-Q for the quarter ended June 30, 2026

  • In its 10-Q for the quarter ended June 30, 2026, Omada Health reported revenue of $87.8 million, net income of $5.3 million, and a gross margin of 72.6%.
  • The company's revenue increased 43.1% year over year.

From the filing

Item 2.02 Results of Operations and Financial Condition.

Item 2.02 Results of Operations and Financial Condition.

On November 5, 2026 , Omada Health, Inc. (the "Company") issued a press release announcing its financial results for the three months ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K1 and is incorporated herein by reference.2

The information furnished pursuant to Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number Exhibit Description

99.1 Press Release, dated November 5 , 2026.

104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OMADA HEALTH, INC.

Date: November 5, 2026

By: /s/ Sean Duffy

Sean Duffy

Chief Executive Officer

Omada Health Reports Third Quarter 2026 Results

• Quarterly Revenue of $91 million and All-Time High Total Members of 1.1 million

• Revenue Grew 34% and Total Members Increased 36% Year over Year

• Raises Full Year 2026 Financial Outlook

SAN FRANCISCO - November 5, 2026 - Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the third quarter ended September 30, 2026.

Financial Highlights

• Revenue of $91 million, compared with total revenue of $68 million in Q3 2025 • Gross margin of 76% in the third quarter, up from 66% in Q3 20253 • Non-GAAP gross margin of 78% in the third quarter, up from 68% in Q3 2025 • Net income of $7 million in the third quarter, compared with a net loss of $3 million in Q3 20254 • Adjusted EBITDA of $12 million in the third quarter, compared with Adjusted EBITDA of $2 million in Q3 2025 • Trailing 12-month revenue per Total Member grew approximately 5% year over year to $294

• Cash and cash equivalents of $243 million

Please see the non-GAAP Financial Measures section below and reconciliations of GAAP to non-GAAP measures at the end of this press release.

Operational Highlights

• Total Members reached 1.1 million, increasing 36% year over year5, reflecting continued demand across Omada Health's integrated cardiometabolic care platform and strong enrollment momentum across diabetes and hypertension programs.

• Average member tenure grew 10% year over year to approximately 2 years and 4 months6, which is roughly an additional 2.5 months in program.

"Omada Health delivered its strongest quarter yet, with revenue growing 34% year over year, Total Members increasing 36% and a GAAP gross margin of 76%," said Sean Duffy, co-founder and CEO of Omada Health. "Our diabetes and hypertension programs led that growth, and average tenure in our programs reached a record of roughly two years and four months. That gives members more time to build lasting habits and the confidence to manage their health."

Financial Outlook

For the year ending December 31, 2026, Omada Health expects:

• Revenue in the range of $344 million to $346 million, up from prior guidance of $334 million to $340 million7, with the midpoint representing approximately 33% growth compared with 2025.

• Adjusted EBITDA in the range of $32 million to $34 million, up from prior guidance of $21 million to $27 million, with the midpoint representing an improvement of approximately $27 million, or roughly five and a half times, compared with 2025.

We have not provided an outlook for net income (loss) (GAAP) or a reconciliation of expected Adjusted EBITDA to net income (loss) (GAAP) because net income (loss) (GAAP) on a forward-looking basis is not available without unreasonable effort8 due to the potential variability and complexity of the items that are excluded from Adjusted EBITDA, such as loss on debt extinguishment; provision for income taxes; depreciation and amortization; share-based compensation; change in fair value of warrant liabilities; amortization of intangible assets; and loss on disposal of property and equipment.

Conference Call

Omada Health will host a conference call at 1:30 p.m.9 9PT/4:30 p.m.9 9ET today, November 5, 2026, during which management will discuss third quarter 2026 results.9

A live audio webcast of the call will be available online at https://investors.omadahealth.com. A replay will be available shortly after the conclusion of the call at the same link and will remain accessible for approximately 12 months.

Those participating via conference call can preregister using the following link:

https://register-conf.media-server.com/register/BIcb6fa0e5bd8d4b91a30bc5b4de7e5fb8

About Omada Health

Omada Health (Nasdaq: OMDA) is reverse engineering the way healthcare is delivered in America, putting the space between doctor visits–where health is won or lost–at the center of care. Today's healthcare system poorly serves chronic conditions that require ongoing support outside of the exam room, like obesity, diabetes, hypertension, cholesterol, and musculoskeletal conditions. Omada Health's virtual-first model combines human-led care teams, connected devices, and AI-enabled technology to deliver personalized care at scale, including support for GLP-1 therapy. Omada Health has served more than two million members since launch across 2,000+ employers, health plans, pharmacy benefit managers, and health systems. Learn more at omadahealth.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements contained in this press release include, but are not limited to, statements we make regarding our ability to deliver profitable growth, business trends, growth prospects and future financial and operating results, and our financial outlook.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, pro

Similar companies

Companies of similar size in SIC 8000 and related industry codes: the same peer list as the financial tables.

Data on this page was fetched . The filing on SEC.gov is the record.